Wrinkle Treatment
Botox is an FDA-approved, medically safe procedure that smooths dynamic wrinkles and expression lines on the face. It provides a natural appearance while minimizing wrinkles.
Treatment Information
Duration
10-15 minutes
Body Location
Forehead, glabella, crow’s feet, masseter or selected facial muscles after assessment
Preparation
Do not stop prescribed medication on your own. Tell the physician about aspirin, anticoagulants, and any medicine or supplement that may affect bleeding; changes are made only with the prescribing clinician. Report active infection or illness before treatment.
Follow-up Care
Results visible after 3-7 days, full effect within 2 weeks. Repeat every 3-4 months.
How It Is Performed
Botulinum toxin is injected under facial muscles using a fine needle. Quick and well-tolerated.
Botox vs Dermal Filler: Which One Is Right for You?
Botulinum toxin and dermal filler are often discussed together, but they address different tissues and goals. Botulinum toxin can temporarily reduce activity in selected muscles; filler may add volume or structural support in an appropriate patient. This comparison explains general decision factors; an individual choice requires facial assessment, medical history, and examination.
| Criterion | Botox (Botulinum Toxin) | Dermal Filler (Hyaluronic Acid) |
|---|---|---|
| Primary Goal | Relaxes expression muscles to reduce dynamic wrinkles (forehead, glabellar lines, crow's feet). | Restores volume loss, fills static lines and contours (lips, cheeks, nasolabial folds). |
| Mechanism of Action | Blocks acetylcholine release to temporarily reduce muscle contraction. | Delivers hyaluronic acid to tissue; binds water between cells, adds volume and structural support. |
| Procedure Duration | 10–15 minutes | 30–45 minutes |
| Onset of Results | 3–7 days, full effect at 2 weeks | Immediately visible; settles over 1–2 weeks as swelling resolves |
| Longevity | 3–4 months | 9–18 months depending on product |
| Reversible? | Its effect fades over time; there is no standard method that immediately reverses treatment. | Some hyaluronic-acid fillers may be reduced with physician-directed hyaluronidase; the speed and extent of response vary. Suspected vascular occlusion requires urgent assessment. |
| Downtime | Return to routine is often quick; bruising, headache, or temporary asymmetry can occur. | Swelling and bruising can occur; duration varies by area, product, and individual response. |
| Findings That Guide the Choice | Lines driven by muscle movement, muscle strength, and the balance of adjacent structures. | Volume loss, contour needs, tissue quality, and vascular anatomy. |
| How Is the Fee Determined? | The muscles assessed, dose, product, and review plan are determined after physician examination. | Product type, amount, treatment area, technique, and follow-up plan are determined after physician examination. |
Dr. Gemici's Recommendation
Movement-related lines may prompt a botulinum-toxin assessment, while volume or structural-support needs may prompt a filler assessment. Some people may be considered for both approaches at different times, but age alone is not a decision rule. Suitability, expected benefit, and risks should be discussed during an in-person physician assessment.
Frequently Asked Questions
No, results typically appear after 3-7 days and full effect develops within 2 weeks.
Botox effects last 3-4 months. With regular treatment, results can be maintained.
Minimal discomfort is experienced. Most patients do not need additional anesthesia, but topical anesthesia can be applied if requested.
Pregnant, nursing, or patients with neuromuscular disorders or botulinum toxin allergy should not receive it. Full evaluation during consultation.
No, botulinum toxin is cleared from body over time. Side effects are temporary and rare.
Yes, can be combined with fillers, mesotherapy, or skin rejuvenation. Doctor plans for optimal results in same session.
Yes, immediately. Just avoid massaging face and intense exercise for first 24 hours.
Safety and complication management
Wrinkle Treatment is a safe procedure; still, as with any medical treatment, explaining possible side effects and rare complications transparently is part of patient safety. The physician-authored guides below cover these topics in depth.
- Eyelid/brow drooping after Botox (ptosis)Why it happens, how long it lasts and how it is managed — understanding a temporary picture without panic.
- "Botox didn't work" — the real reasonsTiming, dose, technique, product and rare antibody resistance: the physician's differential approach.
- Which side effect is normal, which is urgent?A triage guide separating expected post-treatment reactions from the red flags that need a physician.
This content is informational and does not replace medical advice. At any warning sign, contact the physician who performed the procedure or the nearest medical facility without delay.
Wrinkle Treatment — Related Medical Terms
Deep-dive in our glossary: definition, indications, side effects and FAQs.
Masseter Botox
Masseter botox; It is an aesthetic and medical injection treatment used to slim the jaw shape by reducing muscle volume or to treat bruxism (teeth grinding) with Botulinum toxin type A injected into the masseter muscle located in the corner of the jaw.
Baby Botox
Baby Botox is an intramuscular injection treatment that aims to prevent wrinkles in young patients between the ages of 20-35, with a dose reduced to 30-50% of the classical botox, and gives maximum priority to preserving natural facial expressions.
Forehead Botox
Forehead botox; It is an FDA-approved non-invasive aesthetic procedure that blocks muscle contraction and reduces dynamic lines by injecting Botulinum toxin type A into the frontal muscle (musculus frontalis) and surrounding muscles in order to treat horizontal forehead lines and wrinkles.
Crow's Feet Botox
Crow's feet botox; It is Botulinum toxin type A injection applied to the orbicularis oculi muscle to treat dynamic lines that open out from the corners of the eyes (lateral canthal lines). It is applied in a dose of 6-9 units with a standard 3-point injection pattern and reduces laughing lines for 3-6 months.
microbotox
Microbotox (other names: MesoBotox, Dermal Botox) is the intradermal injection of diluted Botulinum toxin type A into the superficial dermal layer in micro-doses of 0.01-0.03 mL; It aims to improve skin quality, pore tightness, sebum production and sweat production without affecting the facial muscles.
Axillary Hyperhidrosis (Excessive Armpit Sweating)
Axillary hyperhidrosis, primary focal hyperhidrosis coded with ICD-10 R61.0, which causes excessive sweat secretion throughout the day, regardless of stress, due to the hyperactive operation of the eccrine sweat glands in the armpit area due to sympathetic cholinergic innervation; HDSS ≥ 3 is a medical condition that significantly reduces the quality of life of patients and provides 75-90% sweat reduction with Botox gold standard treatment.
Dysport (Abobotulinumtoxin-A)
Dysport is a muscle-nerve blocking injection treatment containing the active ingredient Botulinum toxin type A (abobotulinumtoxin-A) produced by Ipsen, approved by FDA (2009) and TITCK, which reduces dynamic wrinkles by blocking facial expression muscles; It is known as a Botox alternative.
Xeomin (Incobotulinumtoxin-A)
Xeomin (Incobotulinumtoxin-A), produced by Merz Aesthetics (Germany), containing the active substance botulinum toxin type A, purified from the complex protein structure (pure neurotoxin); It is a neuromuscular blocking injection treatment that was approved by the FDA in 2011 for aesthetic glabellar lines and is known for its low immunogenicity profile.
Daxxify (Daxibotulinumtoxin-A)
Daxxify; Botulinum toxin type A product, developed by Revance Therapeutics, containing a peptide stimulator (RTP-004) and approved by the FDA for cosmetic indication in 2022, used in the treatment of glabellar wrinkles; It is a longer-acting alternative to Botox, with an effect duration of up to 6 months.
Jeuveau (Prabotulinumtoxin-A)
Jeuveau; Evolus Inc. It is a botulinum toxin type A neurotoxin injection treatment, containing prabotulinumtoxin-A, produced by Daewoong Pharmaceutical (South Korea), marketed by Daewoong Pharmaceutical (South Korea), approved by the FDA in 2019 primarily for cosmetic indication (glabellar lines), has a dose equivalent to Botox, has a rapid onset of effect (2-3 days) and is positioned with an economical price.
Sources & Regulatory Authorities
Information sourced from official regulatory authority databases (FDA, EMA, TİTCK) and peer-reviewed medical literature. Not a substitute for medical advice; clinical decisions are always individualized.
Product Approvals (FDA / EMA / TİTCK)
- FDA
- FDA
- FDA
- TİTCK
Scientific References (PubMed / Cochrane)
- Carruthers JA, Lowe NJ, Menter MA, et al.. Botulinum toxin type A: a review of its use in the treatment of glabellar frown lines · J Am Acad Dermatol (2002)
- Carruthers JD, Glogau RG, Blitzer A; Facial Aesthetics Consensus Group. Consensus recommendations on the use of botulinum toxin type A in facial aesthetics · Plast Reconstr Surg (2008)
Related Services
Plan an Assessment
Contact Dr. Hamza Gemici’s clinic for individualized assessment and candidacy planning.